NCT06202976

Brief Summary

Currently, mapping the epileptogenic zone is based on a comprehensive preoperative assessment involving clinical, imaging and electrophysiological examinations. To reduce the need for invasive stereoelectroencephalography (SEEG) explorations, electrophysiological and imaging methods have been developed, such as resting-state functional MRI (fMRI) coupled with electroencephalogram and arterial spin-labeling perfusion MRI (ASL-MRI). It has been published that these new methods enable precise delineation of the epileptogenic zone and better preparation for surgery. The aim is to determine whether, in children with focal lesional epilepsy, the combination of ASL-MRI-EEG and resting-state fMRI-EEG enables precise identification of the epileptogenic zone to be defined by SEEG, the current reference examination.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for all trials

Timeline
90mo left

Started Sep 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress54%
Sep 2017Sep 2033

Study Start

First participant enrolled

September 14, 2017

Completed
6.3 years until next milestone

First Submitted

Initial submission to the registry

January 2, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

January 12, 2024

Completed
9.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 13, 2033

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 13, 2033

Last Updated

April 17, 2025

Status Verified

April 1, 2025

Enrollment Period

16 years

First QC Date

January 2, 2024

Last Update Submit

April 14, 2025

Conditions

Keywords

Focal EpilepsyLesional EpilepsyNonlesional Epilepsy

Outcome Measures

Primary Outcomes (1)

  • Determine whether, in children with lesional focal epilepsy, the combination of ASL-MRI-EEG and resting-state fMRI-EEG can accurately identify the epileptogenic zone to be defined by SEEG, today's gold standard.

    15 years

Secondary Outcomes (7)

  • Study the pathophysiology of resistant lesional epilepsies

    15 years

  • Correlate cortical perfusion change on SL-ASMRI and BOLD signal abnormalities on resting-state fMRI

    15 years

  • Compare cortical perfusion abnormalities and resting-state fMRI based on EEG data in MRI.

    15 years

  • Correlate BOLD-MRI perfusion abnormalities with anatomical (DTI (tractography)) and functional (resting-state fMRI) brain connectivity abnormalities.

    15 years

  • Compare ASL-MRI and resting-state fMRI data coupled with EEG to the results of deep electrodes (intracranial EEG - SEEG), which are today's gold standard.

    15 years

  • +2 more secondary outcomes

Study Arms (1)

Patients

Other: Secondary data collection

Interventions

clinical data

Patients

Eligibility Criteria

AgeUp to 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Children with refractory focal epilepsy, possibly due to lesions

You may qualify if:

  • Present with one of the following forms of epilepsy:
  • refractory focal lesional epilepsy
  • rare non-lesional epilepsy
  • Present abnormalities (spikes) on the intercritical EEG
  • Have been selected by the "Epilepsy" multidisciplinary staff.
  • In the case of refractory lesional epilepsy, be required to perform an EEG-video recording using intracranial electrodes (SEEG) as part of the pre-surgical workup.
  • Be affiliated to a health insurance scheme.

You may not qualify if:

  • Requiring general anesthesia for MRI
  • Require sedation specifically for research
  • Have generalized epilepsy
  • Be deprived of liberty or under guardianship.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Necker - Enfants Malades Hospital

Paris, 75015, France

RECRUITING

MeSH Terms

Conditions

Epilepsies, Partial

Condition Hierarchy (Ancestors)

EpilepsyBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 2, 2024

First Posted

January 12, 2024

Study Start

September 14, 2017

Primary Completion (Estimated)

September 13, 2033

Study Completion (Estimated)

September 13, 2033

Last Updated

April 17, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations